Article
A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
Pharmacogenetics and genomics - 1 Mar 2012
Aslibekyan Stella, Kabagambe Edmond K, Irvin Marguerite R, Straka Robert J, Borecki Ingrid B, Tiwari Hemant K, Tsai Michael Y, Hopkins Paul N, Shen Jian, Lai Chao-Qiang, Ordovas Jose M, Arnett Donna K
Abstract excerpt
OBJECTIVE: Despite the evidence in support of the anti-inflammatory and triglyceride-lowering effects of fenofibrate, little is known about genetic determinants of the observed heterogeneity in treatment response. This study provides the first genome-wide examination of fenofibrate effects on systemic inflammation. METHODS: Biomarkers of inflammation were measured in participants of the Genetics of Lipid Lowering...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
